In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages

Journal of Leukocyte Biology

Volumn 70, Issue 6, 2001, Pages 868-872

  Brummer, Elmer ^a,b,c   Maqbool, Anjum ^a   Stevens, David A ^a,b,c  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar macrophages; Conidia; Glucocorticoids

Indexed keywords

DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; LUNG ALVEOLUS; LUNG ASPERGILLOSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN WEIGHT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DEXAMETHASONE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, ALVEOLAR; MICE; PHAGOCYTOSIS;

EID: 0035217135     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Infectious risk factors in the immunosuppressed host
2. Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy
3. Opportunistic infections in endogenous Cushing's syndrome
4. Invasive aspergillosis complicating Cushing's syndrome
5. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases
6. Aspergillosis case fatality rate: Systematic review of the literature
7. Short analytical review: Granulocyte-macrophage colony-stimulating factor more than a hemopoietin
8. GM-CSF: More than a growth factor
9. Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae
10. Therapeutic concentrations of glucosteroids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon
11. Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor (GM-CSF) against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia
12. Granulocyte colony stimulating factor: Animal studies for risk assessment
13. Treatment with recombinant granulocyte colony-stimulating factor (Filgastrim) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice
14. Murine pulmonary macrophages: Evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity
15. Oxidative killing of Aspergillus fumigatus by parallel MPO-dependent and independent pathways
16. Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus
17. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, 2,3-bis-[2-methoxy-4-nitro-5-sulphenyl]-(2H)-tetrazolium-5-carboxamide (XTT)
18. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
19. Killing Aspergillus fumigatus spores by human lung macrophages: A paradoxical effect of heat-labile serum components
20. Lack of involvement of nitric oxide in killing Aspergillus fumigatus conidia by pulmonary alveolar macrophages
21. Suppression of in vitro IFN-γ production by spleen cells of Plasmodium chabaudi infected C57BL/10 mice exposed to dexamethasone at a low dose
22. Differences in the effects of dexamethasone on macrophage nitrite production: Dependence on exposure regimen (in vivo or in vitro) and activation stimuli
23. In vivo bronchoalveolar defense against Rhizopus oryzae and Aspergillus fumigatus
24. Employment of recombinant human granulocyte-macrophage colony-stimulating factor in oesophageal candidiasis in AIDS patients
25. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation
26. Use of cytokines in treatment of acute myelocytic leukemia: A critical review
27. Recombinant GM-CSF reduces lung injury and mortality during neutropenic Candida sepsis
28. Anti-inflammatory effects of granulocyte colony-stimulating factor
29. Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation
30. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulation factor and gamma interferon
31. Kinetics and requirement for activation of macrophages for fungicidal activity: Effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism